Paliperidone
CAS No. 144598-75-4
Paliperidone( 9-hydroxy Risperidone )
Catalog No. M11888 CAS No. 144598-75-4
Paliperidone(Invega) is an atypical antipsychotic. Chemically, paliperidone is the primary active metabolite of the older atypical antipsychotic risperidone.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 45 | In Stock |
|
100MG | 79 | In Stock |
|
500MG | 227 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePaliperidone
-
NoteResearch use only, not for human use.
-
Brief DescriptionPaliperidone(Invega) is an atypical antipsychotic. Chemically, paliperidone is the primary active metabolite of the older atypical antipsychotic risperidone.
-
DescriptionPaliperidone(Invega) is an atypical antipsychotic. Chemically, paliperidone is the primary active metabolite of the older atypical antipsychotic risperidone. It is indicated for the acute and maintenance treatment of schizophrenia.
-
In VitroCell Viability Assay Cell Line:SK-N-SH cells Concentration:50-200 μM Incubation Time:3 h Result:Increased cell viability at dose of 100 and 200 μM.
-
In Vivo——
-
Synonyms9-hydroxy Risperidone
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT| β-adrenergic receptor| Dopamine| H1 receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number144598-75-4
-
Formula Weight426.48
-
Molecular FormulaC23H27FN4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 4mg/ml (9.38 mM); Water: <1mg/ml; Ethanol: <1mg/ml
-
SMILESCC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Richelson E, Souder T. Life Sci. 2000 Nov 24;68(1):29-39.
molnova catalog
related products
-
NGB2904 HCl
NGB2904 is a potent and selective antagonist of dopamine D3 receptor (Ki values are 1.4, 217, 223, 642, > 5000, > 10000 and > 10000 nM for D3, D2, 5-HT2, α1, D4, D1 and D5 receptors respectively).
-
CID-25014542
CID-25014542 is novel inhibitor of Raf kinases.
-
GR 46611
GR 46611 is a selective 5-HT1B and 5-HT1D receptor agonist and can be used in studies about the treatment of epilepsy.